Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pulmonx (LUNG) Cost of Revenue (2019 - 2025)

Pulmonx has reported Cost of Revenue over the past 7 years, most recently at $5.4 million for Q3 2025.

  • Quarterly Cost of Revenue rose 1.66% to $5.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $24.5 million through Sep 2025, up 19.45% year-over-year, with the annual reading at $21.8 million for FY2024, 21.56% up from the prior year.
  • Cost of Revenue was $5.4 million for Q3 2025 at Pulmonx, down from $6.7 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $6.7 million in Q2 2025 and troughed at $500000.0 in Q4 2022.
  • The 5-year median for Cost of Revenue is $4.5 million (2023), against an average of $4.3 million.
  • Year-over-year, Cost of Revenue crashed 85.54% in 2022 and then skyrocketed 875.6% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $3.5 million in 2021, then plummeted by 85.54% to $500000.0 in 2022, then skyrocketed by 875.6% to $4.9 million in 2023, then rose by 26.59% to $6.2 million in 2024, then fell by 11.74% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Cost of Revenue are $5.4 million (Q3 2025), $6.7 million (Q2 2025), and $6.2 million (Q1 2025).